HALEOSLABS1,450.00

HALEOS LABS LIMITED

· Pharma & Health
₹ CrorePeersALBERTDAVDVALIANTLABMEDICOMEDICAMEQZIMLABAAREYDRUGSNECLIFEANUHPHRMcap ₹438 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation14.915.015.5
+ Finance Costs0.00.00.0
+ Interest Income0.10.00.0
+ Fair Value (Gains) / Losses0.00.00.0
+ Other Non-cash Items5.50.0-0.4
+ Other Reconciling Items0.30.0-0.4
Changes in Working Capital
+ Inventories5.013.8-12.4
+ Trade Receivables — Current-5.322.57.8
+ Other Financial Assets — Current-0.00.0-0.0
+ Other Financial Assets — Non-current-0.10.1-0.1
+ Other Current Assets-40.438.6-44.3
+ Other Non-current Assets0.81.1-5.8
+ Trade Payables — Current-0.25.69.1
+ Other Financial Liabilities — Current0.21.3-0.6
+ Other Current Liabilities36.345.947.5
+ Provisions — Current0.40.00.0
Cash from Operating Activities
Profit Before Tax (per I/S)9.826.225.221.6
+ Total Adjustments (incl. Working Capital)17.5144.115.9
Cash from Operations (pre-tax)27.3170.341.1
+ Interest Received — Operating0.00.0-0.1
+ Interest Paid — Operating0.00.0-2.4
+ Other Inflows / (Outflows) — Operating0.0-127.70.3
+ Income Taxes Paid3.08.56.5
Cash from Operating Activities24.334.137.2
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)20.915.357.9
+ Disp of Fixed Assets0.10.40.0
+ Interest Received — Investing0.00.00.1
+ Other Inflows / (Outflows) — Investing2.3-0.0-0.2
Cash from Investing Activities-18.5-15.0-57.9
Cash from Financing Activities
+ Proceeds from Borrowings16.64.140.2
+ Repayment of Borrowings17.617.815.3
+ Payment of Lease Liabilities0.00.60.7
+ Payment of Finance Lease Liabilities-1.2
+ Interest Paid6.34.32.3
+ Dividends Paid0.50.50.5
Cash from Financing Activities-6.6-19.121.4
Net Changes in Cash (pre-FX)-0.7-0.10.7
Net Changes in Cash-0.7-0.10.7
Closing Cash0.6
Reference Items
EBITDA31.145.044.740.9
EBITDA Margin %10.1713.0713.3812.61
Free Cash Flow (CFO − Capex)3.418.7-20.6-20.6
Free Cash Flow to Equity0.71.9
Free Cash Flow per Basic Share11.3761.87-68.27-68.27
Cash Flow to Net Income3.841.822.09
Cash Paid for Taxes3.08.56.5
Cash Paid for Interest6.34.32.3
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.